KRAS Mutations and Primary Resistance of Lung Adencarcinomas to Gefitnib or Erlotinib
Contributor(s):
Varmus, Harold
PLoS Medicine
Miller, Vincent
Kris, Mark
Heelan, Robert
Pao, William
Riely, Gregory J.
Wang, Theresa Y.
Zakowski, Maureen
Ladanyi, Marc
Pan, Qiulu